Catalyst Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.28 |
Market Cap |
$403.19 M |
Shares Outstanding |
102.85 M |
Public Float |
95.51 M |
Address |
355 Alhambra Circle Coral Gables Florida 33134 United States |
Employees | - |
Website | http://www.catalystpharma.com |
Updated | 07/08/2019 |
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. |